Today

Agents

Chat

Arena

Discover

More

App

Aardvark Therapeutics held annual shareholder meeting - AARD News | Rallies

Aardvark Therapeutics held annual shareholder meeting

AARD•2026-08-17

Annual shareholder meeting results

Aardvark Therapeutics held its 2026 annual shareholder meeting on Aug. 14, 2026.

Shareholders ratified BDO USA as independent auditor for the year ending Dec. 31, 2026.
Investors also backed a repricing of certain outstanding stock options under the 2017 Plan, 2025 Plan, and 2025 Inducement Plan.

Related News

Datadog director Matthew Jacobson disposes of Class A shares worth $14.99 million

DDOG•2026-08-17

Liberty Capital director John C. Malone acquires 1,000 common shares for $26,000

GLIBA•2026-08-17

UGI Utilities prices USD 125 million 5.45% senior notes due 2031 in private placement

Sources

S

Aardvark Therapeutics held annual shareholder meeting

Sec

UGI

•

2026-08-17

ServiceNow director Paul Edward Chamberlain disposes of 1,500 shares worth $188,400

NOW•2026-08-17

Ares Management disposes of 23,000,000 Savers Value Village shares for $235.75 million

SVV•2026-08-17